These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27785569)

  • 21. [Clostridium difficile remains a medical challenge].
    Nyč O; Krůtová M
    Rozhl Chir; 2017; 96(10):411-414. PubMed ID: 29308906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile diarrhea.
    Williams CN
    Can J Gastroenterol; 1999 May; 13(4):293-4. PubMed ID: 10360986
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
    Brodszky V; Gulácsi L; Ludwig E; Prinz G; Banai J; Reményi P; Strbák B; Kertész A; Kopcsóné Németh I; Zsoldiné Urbán E; Baji P; Péntek M
    Orv Hetil; 2013 Jun; 154(23):890-9. PubMed ID: 23728312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving Strategies to Manage Clostridium difficile Colitis.
    Bowman JA; Utter GH
    J Gastrointest Surg; 2020 Feb; 24(2):484-491. PubMed ID: 31768834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
    Truong CY; Gombar S; Wilson R; Sundararajan G; Tekic N; Holubar M; Shepard J; Madison A; Tompkins L; Shah N; Deresinski S; Schroeder LF; Banaei N
    J Clin Microbiol; 2017 May; 55(5):1276-1284. PubMed ID: 28250001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection.
    Burke DG; Harrison MJ; Fleming C; McCarthy M; Shortt C; Sulaiman I; Murphy DM; Eustace JA; Shanahan F; Hill C; Stanton C; Rea MC; Ross RP; Plant BJ
    J Cyst Fibros; 2017 Mar; 16(2):291-298. PubMed ID: 27908697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiology of Clostridium difficile infection].
    Szczesny A; Martirosian G
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
    Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
    Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridioides difficile infections: Epidemiology, correlations and treatment in a Lebanese cohort with use of ATLAS scoring.
    Choucair J; Waked R; Haddad E; Chedid M; Chehata N; Saliba G; Dahboul H
    J Infect Dev Ctries; 2020 Dec; 14(12):1461-1465. PubMed ID: 33378291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile-associated infection: a disease of varying severity.
    Jawa RS; Mercer DW
    Am J Surg; 2012 Dec; 204(6):836-42. PubMed ID: 23036604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic-induced diarrhea and pseudomembranous colitis.
    Jacobs NF
    Postgrad Med; 1994 Jun; 95(8):111-4, 117-20. PubMed ID: 8202415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines].
    Beneš J; Husa P; Nyč O; Polívková S
    Klin Mikrobiol Infekc Lek; 2014 Jun; 20(2):56-66. PubMed ID: 25135141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomembranous colitis: causes and cures.
    Surawicz CM; McFarland LV
    Digestion; 1999; 60(2):91-100. PubMed ID: 10095149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.